Non-cardioembolic Ischemic Stroke
📧 Sign up to get email alerts when something new happens for Non-cardioembolic Ischemic Stroke.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. [Phase 2]
Phase 2 trial evaluating dosing and safety of BAY 2433334, an oral FXIa inhibitor, in patients after acute non-cardioembolic ischemic stroke…